weeks

Genomic sequences processed in minutes, rather than weeks

A new computational tool developed at the Department of Energy's Pacific Northwest National Laboratory is speeding up our understanding of the machinery of life -- bringing us one step closer to curing diseases, finding safer ways to clean the environment and protecting the country against biological threats. ScalaBLAST is a sophisticated "sequence alignment tool" that can divide the work...

Bacteria can survive for weeks on hospital surfaces

A major cause of hospital-acquired infections can persist for days and even weeks on environmental surfaces found in healthcare settings, including bed linens, computer keyboard covers and acrylic fingernails, according to research presented today at the 105th General Meeting of the American Society for Microbiology. Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of ho...

New influenza vaccine takes weeks to mass produce

Using cell-based methods researchers have developed a commercially viable method for mass producing effective vaccines against potential pandemic influenza strains in weeks instead of the months required for traditional egg-based vaccines. They report their results today at the 2006 ASM Biodefense Research The next flu pandemic could happen any time," says Keyang Wang, a scientist at Prote...

weeks at Biology Products

No data found

Search weeks biology products at Google

Search weeks biology products at Yahoo

Search weeks biology products at Msn

weeks at Biology Technology

Ready to leave? Why you shouldn't give two weeks' notice

The "Exit Stage Right" article on Why? Because giving two week's notice (let alone four week's notice) went out with nickel beers. The article also needs a reality check on some of its observations and assertions of how life is in today's corporate...

Employees debate ethics of giving two weeks' notice

About a year ago, I wrote a column criticizing an "advice article" in the Chicago Tribune about the practice of giving two-week notices when leaving a company. ( ) It was published both on ePrairie and with the Wisconsin Technology Network (WTN). The Wisconsin copy was left...

weeks at Medicine News

Glaxo launches pills to help smokers quit in 7-12 weeks

GLAXO SmithKline India has launched an oral treatment for smoking, called Zyban. The pill (generic - Bupropion Hydrochloride) is reportedly the first product aimed at stopping smoking and is available at Rs. 40 per tablet. Speaking to newspersons, Mr. Kalyanasundaram, Director (Pharmaceuticals), Glaxo India Ltd, said the complete treatment osts about Rs. 5000 and takes about 7-12 weeks....

Answer on SARS 3 to 4 weeks away

The World Health Organization said that it should take three to four weeks for it to fully understands about SARS in China. Since mid-February, an international team from WHO has been working with the Beijing government and now WHO are a full partner with China in the investigation of SARS. China has 1,435 cases of severe acute respiratory syndrome - SARS, accounting for about half of the...

World SARS-free within weeks

The World Health Organisation said the world should be free of the deadly SARS virus within the next two to three weeks, but warned the disease could emerge in China again next winter. "All countries are probably now going to be SARS-free within the next two-to-three weeks. SARS will be gone, we believe, from human populations," says WHO. Taiwan and Toronto -- the only two areas still reg...

Treatment of Breast Cancer with Herceptin for Nine Weeks

A novel approach in the treatment of breast cancer is the new nine week course of Herceptin which also prevents the risk of heart problems.// Herceptin is a monoclonal antibody that attacks the HER-2 protein that is highly expressed in about 30% of the breast cancers. The results of the combination therapy (Herceptin + anthracycline-based chemotherapy) were better when compare...

Breast Cancer Treatment Reduced From Six Weeks To Five Days.

A new therapy to treat breast cancer reduces the radiation time from six weeks to five days. This is very useful for the patients as it is less convenient. Doctors// can point the radiation source at the tumor killing the cancer cells. The study compares the usefulness of the new therapy over the conventional six-week treatment. They are also in the process of analyzing the suitable s...

More>>

weeks at Medicine Products

No data found

Search weeks medicine products at Google

Search weeks medicine products at Yahoo

Search weeks medicine products at Msn

weeks at Medicine Technology

New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility

EXCLAIM is the First International Study to Show That ExtendedThromboprophylaxis Reduces VTE Risk in Acutely-ill Medical PatientsWith a Statistically Significant 44% PARIS, July 8, 2007 /PRNewswire-FirstCall/ --Sanofi-aventisannounced today the results of the EXCLAIM (EXtended CLinicalprophylaxis in Acutely Ill Medical patients) study, which showedthe benefit of extended prophylaxi...

Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes

CHICAGO--(BUSINESS WIRE)--Jun 23, 2007 - Late breaking datapresented at the American Diabetes Association (ADA) 67th AnnualScientific Sessions showed that, when used investigationally asinitial therapy, JANUVIA(TM) (sitagliptin) in combination withmetformin provided significant glycemic improvement and wasgenerally well tolerated over 54 weeks in patients with type 2diabetes. Additional new...

Valopicitabine Combined with Standard of Care Cleared Hepatitis C Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a Phase II Trial

~ Valopicitabine achieved both primary and secondary endpoints ofstudy; no negative drug-drug interaction was observed betweenvalopicitabine and ribavirin ~ CAMBRIDGE, Mass., June 12, 2007 /PRNewswire-FirstCall/ -- IdenixPharmaceuticals, Inc. today announced results from a phase II studydesigned to evaluate triple combination therapy, consisting ofvalopicitabine (NM283), Idenix's lead dru...

Separate Sets of Research Show Treatment Improved Quality of Life in as Early as Three Weeks; Patient Adherence to Medication is Multifactorial

WASHINGTON, May 22, 2007 /PRNewswire/ -- Results from analyseslooking at factors contributing to successful treatment ofulcerative colitis (UC), were presented at Digestive Disease Week(DDW) this week. Both of these studies were funded by Procter &Gamble (P&G) Pharmaceuticals, Inc. Findings from one studyoffer new information on improvement of quality of life for UCpatients t...

Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load Reduction Compared to Adefovir at 48 Weeks in Study of Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients

WASHINGTON, May 21, 2007/PRNewswire-FirstCall/ -- Bristol-MyersSquibb Company (NYSE: BMY) today announced new data from studyETV-079, which showed that treatment with Baraclude (entecavir)demonstrated greater viral load reduction than adefovir at 48 weeks-- a result that was also seen at weeks 12 (primary endpoint) and24. These data from an open-label, randomized viral kinetics studyof 6...

More>>